The results of the screens highlighted several genes (CHD1L, BRCA1, MUS81, RNASEH2A, and XRCC1) previously associated with PARPi sensitivity (1, 25, 26, 31–34) and identified 19 DRG that potentially represent novel PCa vulnerabilities. The gene discussed is XRCC1; the disease is posterior cortical atrophy.